Testicular Cancer
Testicular germ cell cancer has been increasing among men during most of the 20th century. Despite this increase, the etiology of testicular cancer is poorly understood. To better understand the molecular epidemiology of testicular cancer, the National Cancer Institute and the Department of Defense are conducting a case-control study of testicular cancer among military servicemen. The project includes obtaining biosamples and questionnaire data from all participants. Pre-diagnostic serum samples are available from the approximately 1,100 cases and 1,100 controls enrolled in the study. Mothers of all participants are also invited to participate by donating a biosample and responding to a questionnaire. More information, Katherine McGlynn.
The Testicular Cancer Consortium (TCC)
The Testicular Cancer Consortium (TCC) is an active collaboration of scientists conducting epidemiologic research to elucidate the etiology of testicular cancer. It was formed in 2005, with the intent to pool data, biological specimens, and other resources across existing and planned studies of testicular cancer to examine etiologic hypotheses of shared interest. More information, Katherine McGlynn.
Collaborators
|
|
|
|
NCI STEED Study
|
Yale/Harvard TEAMS Study
|
Fred Hutchinson Cancer Research Center Atlas Study
|
The Consortium held an inaugural meeting in April 2006, in conjunction with the annual meeting of the American Association of Cancer Research.
Funding awarded by the Office of Rare Diseases of the National Institutes of Health (NIH) will support a workshop on testicular cancer in March 2007, during which TCC members will reconvene to set priorities, share ideas, and discuss ongoing and future activities in testicular cancer research.
For more information about the consortium or to obtain an agenda or list of participants from our inaugural meeting in April 2006, please complete the Testicular Cancer Consortium form.
